Impact of diabetes on the severity of liver disease

被引:180
作者
Hickman, Ingrid J.
Macdonald, Graeme A.
机构
[1] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia
[2] Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia
关键词
cirrhosis; fatty liver disease; insulin resistance; obesity;
D O I
10.1016/j.amjmed.2007.03.025
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The prevalence of type 2 diabetes is higher in patients who have liver diseases, such as nonalcoholic fatty liver disease, chronic viral hepatitis, hemochromatosis, alcoholic liver disease, and cirrhosis. The development of diabetes in patients with cirrhosis is well recognized, but evidence is emerging that the development of chronic liver disease and progression to cirrhosis may occur after the diagnosis of diabetes and that diabetes plays a role in the initiation and progression of liver injury. This article provides an overview of the evidence for an increased prevalence of diabetes in a range of liver diseases; the effect of diabetes on the severity of disease; the potential mechanisms whereby coexistent diabetes exacerbates progression of hepatic fibrosis; and the impact of obesity, insulin resistance, and type 2 diabetes on clinical outcomes. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:829 / 834
页数:6
相关论文
共 75 条
[1]
The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies [J].
Adams, LA ;
Sanderson, S ;
Lindor, KD ;
Angulo, P .
JOURNAL OF HEPATOLOGY, 2005, 42 (01) :132-138
[3]
ADAMS PC, 1991, AM J MED, V90, P445
[4]
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[5]
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Piper, P ;
Hardies, LJ ;
Glass, L ;
Cersosimo, E ;
Pratipanawatr, T ;
Miyazaki, Y ;
Defronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :200-206
[6]
A PROSPECTIVE POPULATION-BASED STUDY OF ALCOHOL-USE AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BALKAU, B ;
RANDRIANJOHANY, A ;
PAPOZ, L ;
ESCHWEGE, E .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (12) :1469-1470
[7]
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[8]
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[9]
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease [J].
Bugianesi, E ;
Gentilcore, E ;
Manini, R ;
Natale, S ;
Vanni, E ;
Villanova, N ;
David, E ;
Rizzetto, M ;
Marchesini, G .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (05) :1082-1090
[10]
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity [J].
Bugianesi, E ;
Pagotto, U ;
Manini, R ;
Vanni, E ;
Gastaldelli, A ;
de Iasio, R ;
Gentilcore, E ;
Natale, S ;
Cassader, M ;
Rizzetto, M ;
Pasquali, R ;
Marchesini, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) :3498-3504